Performance
The first quarter of 2025 saw stocks and equity-linked convertible bonds drop in response to the Trump Administration’s threats to impose steep tariffs on most U.S. trading partners. A bright spot for convertibles is that they have held up relatively well compared to the decline in equities. Through the recent nadir on April 8th, 2025, the S&P 500, NASDAQ Composite, and Russell 2000 were down 14.99%. 20.78, and 20.77%, respectively, or an average of 18.85%*. For the same period, the ICE BofA U.S. Convertible Index was down 7.61% for a downside capture of 41% which is somewhat better than the typical downside capture rate of 50%.
Coming into the year, the average convertible bond was trading within five points of its par value providing for decent downside support in the event that underlying equities moved lower. This compares favorably to 2022 when the average bond price began the year well above par, making them sensitive to moves in the underlying equities which afforded little bond protection when stock prices dropped sharply. Given the current balanced nature of most of the market, i.e. bonds trading close to par value, convertible should continue to offer downside support in a falling equity market but still participate in much of the upside should stocks rally off their recent lows.
*Source: Bloomberg
Issuance
Through the end of the first quarter of 2025, new issuance totaled $15.3 billion, (from Bank of America data) or an annualized rate of $60 billion, which while below last year’s $87 billion total, is still a healthy rate of primary issuance. With the onset of volatility in the stock market and the sharp drop in price of many shares, companies may be more reluctant to issue a new equity-linked security, but those companies that need the infusion of cash are still likely to come to the market as it may be their best or perhaps only realistic opportunity to raise funds. The only new issue thus far in April came from electric vehicle manufacturer, Lucid Motors, which sold $1.1 bil of new convertible debt despite a stock price below $2.50.
Should volatility in the equity markets subside, we would expect new issuance to resume a more normal rate as many companies that issued debt during the pandemic need to refinance upcoming maturities. Companies that cannot refinance that debt from operating cash flow are likely to sell new debt through initial public offerings.
Positioning and Outlook
While the economy was reasonably healthy coming into the year, there remains a significant risk that consumer and business spending declines due to the imposition of new tariffs. Stocks were trading at historically high valuations prior to the recent selloff and arguably are not cheap even after the recent decline. We are not incorporating any macro-economic view into our investment decisions, as our investment process is focused on company-specific fundamentals. In the wake of the recent selloff, however, we have lightened our holdings of several bonds in the Healthcare sector where either company fundamentals have deteriorated or the bonds had fallen to a level where they no longer had much equity sensitivity. We added to several holdings, particularly in the Information Technology sector, where fundamentals remain strong and the issuing company’s bonds have a balanced profile so that they should participate meaningfully in any eventual share price recovery. We remain overweight the Healthcare sector and underweight Utilities and our portfolio has held up relatively well in the recent downturn. We continue to believe that our process which emphasizes strong company fundamentals and reasonable valuation will outperform over a complete market or economic cycle.
IMPORTANT DISCLOSURE
Availability of products and services provided by MacKay Shields may be limited by applicable laws and regulations in certain jurisdictions and this document is provided only for persons to whom this document and the products and services of MacKay Shields may otherwise lawfully be issued or made available. None of the products and services provided by MacKay Shields are offered to any person in any jurisdiction where such offering would be contrary to local law or regulation. This document is provided for information purposes only. It does not constitute investment advice and should not be construed as an offer to buy securities. The contents of this document have not been reviewed by any regulatory authority in any jurisdiction. All investments contain risks and may lose value and these materials do not undertake to explain all of the risks associated with any investment strategy referred to herein. Clients and investors should not invest in any strategy referred to herein unless satisfied that they and/or their representatives have requested and received all information that would enable them to evaluate the merits and risks thereof. Any forward-looking statements speak only as of the date they are made, and MacKay Shields assumes no duty and does not undertake to update forward looking statements. Any opinions expressed are the views and opinions of certain investment professionals at MacKay Shields which are subject to change without notice. There may have been, and may in the future be, changes to the investment personnel responsible for the management of the strategy(ies) described herein, as well as changes to the investment process utilized by such investment personnel. It is not possible to invest directly in an index. Past performance is not indicative of future results.
No part of this material may be reproduced in any form, or referred to in any other publication, without the express written permission of MacKay Shields. © 2025 MacKay Shields LLC. All rights reserved.
NOTE TO UK AND EUROPEAN UNION RECEIPIENTS
This document is intended only for the use of professional investors as defined in the Alternative Investment Fund Manager’s Directive and/or the UK Financial Conduct Authority’s Conduct of Business Sourcebook. To the extent this document has been issued in the United Kingdom, it has been issued by NYL Investments UK LLP, 200 Aldersgate Street, London UK EC1A 4HD, which is authorised and regulated by the UK Financial Conduct Authority. To the extent this document has been issued in the EEA, it has been issued by NYL Investments Europe Limited, 77 Sir John Rogerson's Quay, Block C Dublin D02 VK60 Ireland. NYL Investments Europe Limited is authorized and regulated by the Central Bank of Ireland (i) to act as an alternative investment fund manager of alternative investment funds under the Alternative Investment Fund Managers Directive (Directive 2011/61/EU) and (ii) to provide the services of individual portfolio management, investment advice and the receipt and transmission of orders as defined in Regulation 7(4) of the AIFMD Regulations to persons who meet the definition of “professional client” as set out in the MiFID Regulations. It has passported its license in additional countries in the EEA.
MacKay Shields LLC is a wholly owned subsidiary of New York Life Investment Management Holdings LLC, which is wholly owned by New York Life Insurance Company. "New York Life Investments" is both a service mark, and the common trade name of certain investment advisers affiliated with New York Life Insurance Company. Investments are not guaranteed by New York Life Insurance Company or New York Life Investments.
Subscribe to get MacKay Shields insights delivered to your inbox.
Related Thought Leadership